Vildagliptin improves vascular smooth muscle relaxation and decreases cellular senescence in the aorta of doxorubicin-treated rats
CONCLUSION: In summary we conclude that vildagliptin can reduce senescence and improve relaxation of vascular smooth muscle in the aorta of DOX-treated rats, and GLP-1 can reduce senescence of DOX-treated VSMCs. These data suggest that incretin-based drugs are promising candidates for patients suffering from late doxorubicin cardiovascular toxicity.PMID:33744414 | DOI:10.1016/j.vph.2021.106855
Source: Vascular Pharmacology - Category: Drugs & Pharmacology Authors: Svetoz ár Mišúth Mar ína Uhrinová J án Klimas Diana Vavrincov á-Yaghi Peter Vavrinec Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Incretin Therapy | Sodium | Toxicology